Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dalton Pharma Successfully Completes Inspection | Contract Pharma
Breaking News

Dalton Pharma Successfully Completes Inspection

Dalton Pharma Services has successfully completed its Health Canada audit and has received a 'compliant' rating for its GMP manufacturing facility.

Dalton Pharma Services has successfully completed its Health Canada audit and has received a ‘compliant’ rating for its GMP manufacturing facility. The Establishment License enables the company to continue to manufacture, test and ship sterile commercial products for its clients. Dalton’s solid dose manufacturing suites were also found to be compliant for formulation, granulation and encapsulation of drug products.

In separate audits, the company was also found to be compliant with GMP API manufacturing, sterile filling and testing standards for pharmaceutical products in the EU.

“These successful inspections will allow us to continue to execute on our vision to accelerate drug development for our clients’ pharmaceutical products globally. Dalton’s ability to carry out commercial manufacture of sterile, solid dose pharmaceuticals and API provides integrated drug development and manufacturing solutions. Dalton’s reputation for its ability to complete complex drug manufacturing projects in GMP compliant facilities enhances our clients’ success in bringing the medicines of the future to the market,” said Peter Pekos, president and chief executive officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters